In Brief
Murakoshi, Shin et al. developed a lightinducible inhibitor of CaMKII and demonstrated that a brief illumination of blue light to neurons expressing this inhibitor blocks synaptic plasticity and learning.
SUMMARY
Elucidating temporal windows of signaling activity required for synaptic and behavioral plasticity is crucial for understanding molecular mechanisms underlying these phenomena. Here, we developed photoactivatable autocamtide inhibitory peptide 2 (paAIP2), a genetically encoded, light-inducible inhibitor of CaMKII activity. The photoactivation of paAIP2 in neurons for 1-2 min during the induction of LTP and structural LTP (sLTP) of dendritic spines inhibited these forms of plasticity in hippocampal slices of rodents. However, photoactivation $1 min after the induction did not affect them, suggesting that the initial 1 min of CaMKII activation is sufficient for inducing LTP and sLTP. Furthermore, the photoactivation of paAIP2 expressed in amygdalar neurons of mice during an inhibitory avoidance task revealed that CaMKII activity during, but not after, training is required for the memory formation. Thus, we demonstrated that paAIP2 is useful to elucidate the temporal window of CaMKII activation required for synaptic plasticity and learning.
INTRODUCTION

Ca
2+
/calmodulin kinase II (CaMKII) is required for induction of long-term potentiation (LTP) and the associated structural plasticity of dendritic spines (Lisman et al., 2012) . A holoenzyme of CaMKII consists of 12 subunits, and each subunit is activated by the association of Ca 2+ /calmodulin (Chao et al., 2011; Lisman et al., 2012) . Activation of two adjacent subunits leads to trans-autophosphorylation at Thr-286, which enables autonomous activity after Ca 2+ /calmodulin dissociation (Chao et al., 2011; Lisman et al., 2012; Zhabotinsky, 2000) . Because of this calcium-independent activity, sustained CaMKII activity had been postulated as a mechanism of LTP maintenance. The duration of CaMKII activation during LTP has been measured using biochemical analysis, but the results are inconsistent, with some reports of more than $1 hr (Barria et al., 1997; Fukunaga et al., 1993; Ouyang et al., 1997) and other reports of a much shorter time period (Lengyel et al., 2004) . Recently, using two-photon fluorescence lifetime imaging microscopy (2pFLIM) with a fluorescence resonance energy transfer (FRET)-based CaMKII sensor, we imaged CaMKII activity in dendritic spines during spine enlargement associated with LTP (referred to as structural LTP or sLTP) induced by two-photon glutamate uncaging and demonstrated that CaMKII activation persists for only $1 min (Lee et al., 2009) . While the two-photon FRET-FLIM imaging approach is useful to study the kinetics of CaMKII in single dendritic spines, its application to electrical stimulation-induced LTP has been complicated by the difficulty of locating stimulated spines among $10,000 in each transfected neuron. As a complementary approach, the temporal requirement of CaMKII activation for LTP induction has been measured by using pharmacologic inhibitors. It has been shown that application of CaMKII inhibitors before LTP induction inhibits LTP expression, whereas application after LTP establishment does not inhibit LTP expression (Buard et al., 2010; Chen et al., 2001; Malinow et al., 1989; Otmakhov et al., 1997) , consistent with the transient CaMKII activation found by two-photon FRET-FLIM imaging (Lee et al., 2009) . It also has been reported that the interaction between CaMKII and the N-methyl-D-aspartate receptor (NMDAR) is critical for both induction and expression of LTP using CN21, a peptide derived from a natural CaMKII inhibitor that inhibits CaMKII activation at low concentration and disrupts CaMKII-NMDAR interaction at high concentration (Sanhueza et al., 2011) . However, the prolonged time required for bath-applied pharmacologic inhibitors to reach intracellular compartments in brain slices precludes the precise measurement of the temporal requirement of CaMKII activation for LTP expression. In addition, it is difficult to distinguish between the requirement of basal kinase activity and stimulation-evoked activity with pharmacological analyses.
Here, in order to measure the precise temporal requirement of CaMKII activation for synaptic plasticity, we developed paAIP2, a photoactivatable CaMKII inhibitor. Its design is based on the light-oxygen-voltage domain 2 (LOV2)-Ja helix domain (404-539) of Phototropin1, which changes its conformation from a closed form to an open form upon blue light absorption (Wu et al., 2009 ). This light-controllable conformation change has been utilized for various types of photoactivatable proteins (Tischer and Weiner, 2014) . Using a similar approach, we fused autocamtide inhibitory peptide 2 (AIP2), a potent CaMKII inhibitory peptide (Ishida et al., 1998) , to LOV2-Ja in order to inhibit CaMKII in a light-dependent manner. After validation of the paAIP2, we measured the temporal requirement of CaMKII activation for structural plasticity of dendritic spines and high-frequency stimulation (HFS)-induced LTP, as well as an inhibitory avoidance (IA) task (Irvine et al., 2005; Yamagata et al., 2009) .
RESULTS
Photoactivatable AIP2 Specifically Inhibits CaMKII in a Light-Dependent Manner
We designed paAIP2 so that LOV2-Ja in the closed conformation blocks the action of AIP2 due to steric hindrance, but upon light absorption, LOV2-Ja transitions to an open conformation and allows for AIP2-mediated inhibition of CaMKII. This ''onstate'' is reversed spontaneously as LOV2-Ja returns to its closed conformation (Wu et al., 2009) , ending the inhibitory action of paAIP2 on CaMKII ( Figure 1A ). To test the efficacy of paAIP2, we measured kinase activity of full-length CaMKIIa in the presence of paAIP2 in a cell-free assay. Autophosphorylation of T286 in CaMKIIa and phosphorylation of synapsin site 1 parent peptide (Syn1) (White et al., 1998) , a CaMKIIa substrate peptide, were monitored by western blotting to assess CaMKII activity. Regardless of the presence of paAIP2, the phosphorylation of T286 and Syn1 similarly increases with the addition of ATP in the absence of blue light ( Figure 1B ). In contrast, blue light illumination at 3 mW/cm 2 strongly inhibited phosphorylation of Syn1 in the presence of paAIP2, but not in its absence ( Figures  1B and 1C) . When we used a low-affinity paAIP2 R5A/R6A , which has an approximately 10 4 -fold lower affinity to CaMKII than that of wild-type AIP2 (Ishida et al., 1998) , CaMKII activity was not inhibited even under blue light illumination. This result suggests that the inhibitory effect is due to the action of the AIP2 in paAIP2 (Figures 1B and 1C ). Similar to another peptide inhibitor CN-21 (Vest et al., 2007) , paAIP2 did not inhibit autophosphorylation at Thr-286 but did inhibit phosphorylation of a CaMKII substrate ( Figure 1C ). Ca 2+ -independent, autonomous activity of CaMKII was also inhibited by paAIP2 ( Figure 1D ). PaAIP2 with a constitutively open LOV2 I539E showed only a slightly reduced potency compared to AIP2 alone ( Figure 1E) . The relationship between the degree of inhibition and the light intensity revealed that an intensity of $1 mW/cm 2 is sufficient to substantially inhibit CaMKII activity ( Figure 1F ). To test the specificity of paAIP2, we measured the activity of various purified kinase domains (i.e., constitutively active forms) derived from major kinases-CaMKIIa, CaMKIV, PKCa, PKA, CaMKI, PAK3, and ROCK2-for phosphorylating against Syn1. In the absence of paAIP2, all of these kinases phosphorylated Syn1 (Figure 2 ). When paAIP2 with a constitutively open form of LOV2 I593E was included in the solution (3-30 mM), the phosphorylation by CaMKIIa was inhibited with high efficacy and potency (>85%), but not by other kinases, suggesting that paAIP2 is a specific inhibitor of CaMKII (Figure 2) . Notably, unlike KN62 and KN93 , but as with AIP2 (Ishida et al., 1995 (Ishida et al., , 1998 , paAIP2 did not inhibit activity of CaMKI and CaMKIV. Consistent with the action of paAIP2 in a cell-free assay, immunoblot analysis demonstrated that paAIP2 expressed in dissociated neurons slightly inhibited autophosphorylation of CaMKII at T286 ( Figure S1A ) but strongly inhibited phosphorylation of SynGAP, a target of CaMKII, in a light-dependent manner ( Figure S1B ). In addition, the phosphorylation of Neuromodulin, a PKC substrate, and other PKC and PKA substrates were much less affected by paAIP2 ( Figures S1C-S1E ). These results suggest that paAIP2 is a specific inhibitor of CaMKII.
To test the kinetics of CaMKII inhibition in cells, we transfected mCherry-AIP2 or mCherry-paAIP2 and monomeric enhanced green fluorescence protein (mEGFP)-CaMKIIa into HeLa cells and measured their binding using 2pFLIM ( Figures 3A-3D ). Elevation of intracellular Ca 2+ levels by the application of ionophore (A23187) rapidly increased the binding between mEGFP-CaMKIIa and mCherry-AIP2 ( Figures 3B and  3C ), consistent with findings that AIP2 is a pseudo-peptide competitive inhibitor (Ishida et al., 1995 (Ishida et al., , 1998 . In contrast, mCherry-paAIP2 did not bind to mEGFP-CaMKIIa upon ionophore stimulation but rapidly bound to mEGFP-CaMKIIa upon light illumination and dissociated over $40 s ( Figures 3B and  3C ). This could be repeated many times with blue light pulses, demonstrating its reversibility ( Figure 3D ). Constitutively active paAIP2 I539E showed a similar time course to mCherry-AIP2, whereas low-affinity paAIP2 R5A/R6A did not show any change in binding ( Figure 3C ). These results show that paAIP2 binds to CaMKIIa in a light-dependent and reversible manner in HeLa cells.
Next, since the association of CaMKII with the C-terminal tail of the GluN2B subunit of NMDA receptors plays an important role in autonomous CaMKII activity and LTP (Bayer et al., 2001; Zhou et al., 2007) , we tested whether the interaction between CaMKII and the CaMKII interaction domain of GluN2B 1277-1328 is affected by paAIP2 ( Figure S2 ). We monitored binding between mCherry-GluN2B 1277-1328 and mEGFPCaMKIIa in HeLa cells by 2pFLIM. Ionophore application rapidly increased the binding between mEGFP-CaMKIIa and mCherryGluN2B 1277-1328 , suggesting that the CaMKII-GluN2B interaction requires CaMKII activation ( Figures S2B and S2C ). However, in the presence of LOV2 I539E -AIP2 or LOV2 I539E -GluN2B, the binding between mCherry-GluN2B 1277-1328 and mEGFPCaMKIIa was significantly inhibited (Figures S2C and S2D) . In contrast, the low-affinity mutant LOV2 I539E -AIP2 R5A/R6A did not affect the CaMKII-GluN2B interaction ( Figures S2C and S2D ). These results suggest that paAIP2 inhibits the CaMKII-GluN2B interaction in cells (Figures S2C and S2D) .
We further characterized the kinetics of the structural change of paAIP2 by measuring intra-molecular FRET of mEGFPpaAIP2-ShadowG in HeLa cells (Figures 3E and 3F) (Murakoshi et al., 2015) . As expected from the known conformation of (A) Effect of paAIP2 under blue light was tested on different kinases. Phosphorylation of purified Syn-1 peptide by various active kinases was detected by western blotting. PaAIP2 blocks CaMKII activity at various concentrations while having no effect on other kinases. (B) Quantification of (A). For data analysis, kinase activity of lane 2 was normalized to 100% for each kinase. Error bars indicate SEM for three independent experiments except PAK3 (n = 4). See also Figure S1 .
LOV2-Ja, the constitutively open form of paAIP2 I539E exhibited a longer fluorescence lifetime (lower FRET) ($2.38 ns) than that of wild-type ($2.23 ns) in dark conditions (Figures 3F and 3G) . Upon light illumination, paAIP2 displayed a rapid fluorescence lifetime increase (FRET decrease), which is recovered in $1 min (Figures 3F and 3G) . Constitutively active paAIP2 I539E did not show further increase in the fluorescence lifetime ( Figures  3F and 3G ). The fluorescence lifetime at the peak suggests that $40% of paAIP2 opens under this condition. The low-affinity paAIP2 R5A/R6A exhibited similar open and close kinetics to paAIP2 ( Figures 3F and 3G ). Furthermore, we confirmed that the photoactivation of paAIP2 can be repeated more than 20 times without any fatigue ( Figure 3H ).
Temporal Window of CaMKII Activation Necessary for
Structural Plasticity of Dendritic Spines and LTP Next, we tested whether blue light illumination inhibits CaMKIIdependent plasticity of dendritic spines in CA1 pyramidal neurons in cultured hippocampal slices (Figures 4 and 5). We biolistically transfected hippocampal slices with mEGFP-P2A-mCherry-P2A-paAIP2 plasmid, where the DNA sequences coding mEGFP, mCherry, and paAIP2 were linked together with P2A elements so that these three proteins are expressed separately (Donnelly et al., 2001; McAllister, 2000) . Since the excitation wavelength of paAIP2 overlaps with that of mEGFP, we used red fluorescence from mCherry for identifying neurons by epi-fluorescence microscopy. Fluorescence from mEGFP was used to image single dendritic spines under a two-photon laser scanning microscope because of its superior photostability and brightness under two-photon excitation than that of mCherry. To induce sLTP in a single dendritic spine, we applied a low-frequency train of two-photon glutamate uncaging pulses (30 pulses at 0.5 Hz) to the spine in the absence of extracellular Mg 2+ (Harvey and Svoboda, 2007; Lee et al., 2009; Matsuzaki et al., 2004) . The spine volume increased rapidly by 300%-400% following glutamate uncaging (transient phase) and relaxed to an elevated level of 70%-100% for more than 20 min (sustained phase) ( Figure 4A ), consistent with the previous reports (Harvey et al., 2008; Lee et al., 2009; Matsuzaki et al., 2004) . This suggests that paAIP2 does not affect sLTP under two-photon imaging (<1.5 mW) and uncaging ($5 mW). Widefield illumination by a blue laser (100 mW/cm 2 , 400 mmF) for 1 min during glutamate uncaging significantly inhibited both the transient and sustained spine enlargement (Figures 4A and 4B) (Lee et al., 2009; Matsuzaki et al., 2004; Murakoshi et al., 2011) , demonstrating that CaMKII-dependent plasticity can be inhibited by paAIP2 in a blue-light-dependent manner. In contrast, neither 1-min-long blue light illumination immediately prior to uncaging nor 5-min-long blue light illumination initiated 1 min after uncaging was capable of inhibiting sustained phase spine volume changes ( Figures 4C-4F ), suggesting that CaMKII activity is only required in the early phase of structural plasticity induction. The low-affinity mutant paAIP2 R5A/R6A failed to inhibit spine enlargement (Figures 4G and 4H) , suggesting that blue-lightdependent inhibition of spine plasticity is due to the action of AIP2. Furthermore, we confirmed the reversibility of the inhibitory action of paAIP2 by two sets of glutamate uncaging stimulations delivered to the same spine. Glutamate uncaging with concomitant blue light illumination failed to produce sLTP, whereas the same glutamate uncaging protocol initiated 5 min later in the absence of blue light illumination produced normal spine volume changes ( Figure 4I ). Thus, the inhibitory effect of paAIP2 is reversible in cultured slices just as it is in HeLa cells. Finally, we characterized the relationship between the expression level of paAIP2 and changes in spine volume. The concentration of paAIP2 was measured from mEGFP fluorescence compared to purified mEGFP under the assumption that mEGFP and paAIP2 are equally expressed using the P2A sequence. We found that, through a broad range of expression levels (5-60 mM), paAIP2 inhibited spine structural plasticity to a similar degree ( Figure S3 ).
To further elucidate the precise temporal requirement of CaMKII activity for structural plasticity, we applied blue light for 1 min and glutamate uncaging for 1 min at different timing pairings ( Figure 5A ). When blue light and glutamate uncaging were applied at the same time, both the transient and sustained phases of volume change were inhibited. However, by delaying the blue light application by 10-30 s, the transient phase, but not the sustained phase, was partially restored (Figures 5A and 5B) . When the blue light was shifted by 60 s, normal plasticity for both transient and sustained phases was observed ( Figures 5A and 5B) . These results suggest that the transient and sustained phases of sLTP may have distinct temporal requirements for CaMKII activity.
Next, to study the temporal requirement of CaMKII for a standard HFS-induced LTP, we injected adeno-associated virus (AAV) encoding mEGFP-P2A-paAIP2 under the control of the Camk2a promoter (AAV-mEGFP-P2A-paAIP2) into the hippocampus of mice and prepared acute hippocampal slices from the infected mice. The field excitatory postsynaptic potential (fEPSP) slope was recorded in these slices using an electrode located in CA1 while stimulating Schaffer-Collateral fibers with a bipolar electrode in the presence and absence of blue light (Figure 6A) . When HFS (100 Hz, 1 s, 3 times, 20 s intervals) was applied to the slice, we observed a robust potentiation of fEPSP slopes, indicating that LTP was induced ( Figures 6B-6D ). When blue light was illuminated for $2 min during the LTP induction, LTP was abolished ( Figures 6B-6D) . However, when blue light was applied with a 1 min delay from the first stimulation, we observed normal LTP ( Figures 6B-6D ). When a low-affinity paAIP2 R5A/R6A mutant was used, normal LTP was observed even with blue light ( Figures  6B-6D ). Taken together, these experiments suggest that 1 min of CaMKII activation is sufficient to induce LTP.
The Temporal Window of CaMKII Activation in Amygdala Required for Inhibitory Avoidance Task Finally, we tested the capability of paAIP2 to change an animal's behavior in the inhibitory avoidance learning paradigm, in which mice are placed in the bright compartment of an apparatus with light and dark compartments, and the mice are given a brief foot shock (0.5 mA for 2 s when they enter the dark compartment ( Figure 7A ). Learning to avoid the dark compartment in the inhibitory avoidance paradigm has been previously reported to be CaMKII dependent (Irvine et al., 2005; Yamagata et al., 2009 ). Mice were subjected to double-trial training inhibitory avoidance learning in an inhibitory avoidance apparatus ( Figure 7A ) and tested for the memory maintenance 1 hr after training. Animals were divided into three groups. For the first two groups (''Control'' and ''paAIP2''; Figure 7B ), we bilaterally injected nonfunctional mutant AAV-mEGFP-P2A-paAIP2 R5A/R6A (Control) or AAV-mEGFP-P2A-paAIP2 (paAIP2) into the amygdalae (lateral amygdala and basolateral amygdala) and implanted optical fibers (800 mm F) $200 mm above the brain region ( Figure 7C ; Figure S4 ; Table S1 ). For both groups, blue light was applied through the optical fibers (cycles of 1 s light on at 30 mW and 4 s off) ( Figure 7B ). The light application encompassed the entire training session and lasted for an hour. For the third group, AAV-mEGFP-P2A-paAIP2 was injected in the same region of the brain (amygdalae), but blue light illumination was initiated only after the training ceased and was maintained for the same duration (1 hr) (''time-shift,' ' Figure 7B) . All three groups of animals showed normal behavior and no significant difference in latency during the training ( Figures 7D  and 7E ). Following the light delivery, mice were subjected to a test of the acquired memory. We found that most of the mice in the control group avoided the dark chamber for more than 600 s, the maximum duration of the testing period (n = 16; median = 600 s) ( Figure 7F ). In contrast, the paAIP2 group showed significant impairment: many animals crossed to the dark chamber before the 600 s cutoff point (n = 12: p < 0.01; median = 67.2 s; Kruskal-Wallis test followed by Dunn's test) ( Figure 7F ). The animals in the time-shift group showed a latency comparable to that of the control (n = 15; median = 600 s; p > 0.99) ( Figure 7F ). Taken together, we demonstrated that the activity of CaMKII in the amygdalae during the training session, but not after the training session, is necessary for memory formation.
DISCUSSION
In this study, we developed paAIP2, a photo-inducible CaMKII inhibitor that enables CaMKII inhibition in a light-dependent manner. PaAIP2 presents several advantages over conventional pharmacological inhibition or genetic manipulation. First, it allows researchers to manipulate CaMKII activity with secondto-minute temporal resolution. Second, because it is genetically encoded, it enables the manipulation of CaMKII in a cell-typeand brain-region-specific manner. Third, it has high specificity for CaMKII: the specificity of paAIP2 is similar to that of other peptide inhibitors AIP2 (Ishida et al., 1995 (Ishida et al., , 1998 and CN-21 (Vest et al., 2007) and higher than that of commonly used small drugs, such as KN62 and KN93, which inhibit CaMKI and CaMIV, as well as CaMKII . We applied this tool in several forms of synaptic plasticity and one form of learning and demonstrated that it is useful for dissecting the temporal window of CaMKII activation necessary for these CaMKIIdependent phenomena.
Our analyses of spine structural plasticity using paAIP2 suggest that $10-30 s of CaMKII activation is sufficient for inducing transient spine enlargement, while $60 s is required for sustained spine enlargement (Figures 4 and 5) . These results confirmed our previous results showing that CaMKII activation lasts $1 min during spine structural plasticity (Lee et al., 2009 ). Thus, these complementary studies revealed that both the duration of CaMKII activation during spine structural plasticity and the duration necessary for inducing the plasticity is $1 min. The different temporal requirement between these two phases may be due to differences in the integration properties of downstream signaling. Previously, we showed that Rho GTPases Rac, Rho, and Cdc42 are CaMKII dependent, but they play differential roles in the different phases of structural plasticity (Hedrick et Our study also revealed the temporal requirement of CaMKII activation for HFS-induced LTP to be $1 min, similar to that for spine structural plasticity (Figure 6 ). While the process of glutamate uncaging-evoked spine structural plasticity and HFS-LTP has been thought to be similar (Matsuzaki et al., 2004) , the kinetics of molecular activation during HFS-LTP has not been measured. These results suggest that similar signaling cascades are activated during glutamate uncaging-induced spine structural plasticity and HFS-LTP. Consistent with the relatively short window of CaMKII activation required for LTP and spine enlargement, acute inhibition of CaMKII using paAIP2 during the inhibitory avoidance task displayed that CaMKII activation in the amygdala during the training session, but not after the training session, is necessary for this form of memory. Our studies on HFS-LTP and the inhibitory avoidance task demonstrate that our optogenetic kinase inhibitor allows for measurements of signaling activity in neuronal compartments that are not easily accessible with imaging methods. The light intensity required for inhibiting CaMKII with paAIP2 is orders of magnitude smaller than that required for channel rhodopsin 2 activation (1-100 mW/ cm 2 for paAIP2 versus $1,000 mW/cm 2 for ChRh2; Boyden et al., 2005 ) and thus will not cause significant damage to the tissue. One of the potential future directions is to combine paAIP2 with FRET-based signaling sensors. Previously, we demonstrated that activity of small GTPase proteins Ras, Cdc42, RhoA, and Rac can be monitored with FRET sensors in combination with 2pFLIM, and these molecules are activated downstream of CaMKII (Harvey et al., 2008; Murakoshi et al., 2011; Hedrick et al., 2016) . By combining paAIP2 and these FRET sensors, we should be able to determine the temporal requirement of CaMKII activation for various downstream signaling molecules.
It is relatively straightforward to apply the strategy used in designing paAIP2, i.e., fusion of LOV2-Ja to a protein inhibitor peptide, to create photo-inducible inhibitors for other signaling proteins, including the peptide inhibitors of protein kinase A (PKI) (Yi et al., 2014) and protein kinase C (pseudo-substrate inhibitors). Such light-controllable tools will be useful for analyzing the temporal nature of intracellular signaling cascades.
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H.M. created paAIP2; H.M. and R.Y. designed the experiments; H.M., M.E.S., and E.M.S. performed biochemical experiments; H.M. and A.C.E.S. performed imaging experiments; P.P.-B. and M.E.S. performed electrophysiological experiments; M.E.S. performed behavioral experiments; and H.M., M.E.S., and R.Y. wrote the paper. All the authors discussed the results and commented on the manuscript. Virus Group 500 500 500 μm μm μ μm 500 μm Figure 7 . Inhibition of CaMKII by paAIP2 Impairs Memory Formation in Inhibitory Avoidance Learning (A) A schematic of double-trial training inhibitory avoidance. Upon entering and exploring the light chamber within the inhibitory avoidance apparatus, a mouse is allowed to enter the dark chamber, after which a foot shock is administered. The training is repeated once more. Each training trial ends if the animal crosses or avoids the dark chamber for 120 s. (B) A schematic of light application during inhibitory avoidance. For the control and paAIP2 groups, blue light (0.2 Hz, 1 s) is applied from the onset of training for an hour. For the time-shift group, light delivery begins after the training. Timelines are not drawn to scale. (C) The expression of mEGFP-P2A-paAIP2 in amygdala. The cyan and white triangles indicate the area of transgene expression and the fiber track above amygdala, respectively. The upper region demarcated by white dotted line indicates lateral amygdala (LA). The lower region indicates basolateral amygdala (BLA). Scale bar, 500 mm. Note that animals expressing detectable transgene expression in either LA or BLA in both hemispheres were included in the analyses (D)-(F). (D and E) Cross latency for the first (D) and second (E) training trials. Three groups of mice show no statistically significant difference in cross latency in both training trials. Cutoff latency set at 120 s. Bars represent median. Dunn's multiple comparisons test following Kruskal-Wallis test (n = 16, 12, and 15 for control, paAIP2, and time-shift group, respectively). (F) Cross latency for the memory test (1 hr). Cutoff latency set at 600 s. Bars represent median. p values are from Dunn's multiple comparisons test following Kruskal-Wallis test. See also Figure S4 and Table S1 . 
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
All experimental protocols were approved by Max Planck Florida Institute IACUC, Duke University Medical Center or National Institutes of Natural Sciences and meet the guidelines of the National Institutes of Health guide for the Care and Use of Laboratory Animals.
Animals
For behavioral experiments, C57BL/6 mice (males; Charles River) were individually housed under a reversed 12 hr light/dark cycle with food and water ad libitum. Mice were between 3-5 months old and weighed approximately 27-35 g at the time of the behavior experiments. Mice used in electrophysiological experiments were between 2.5-3 months old and weighed approximately 24-28 g. Littermates were randomly assigned to experimental groups. Animals were not exposed to any previous procedures such as pharmacological treatments or altered diets. All animals exhibited a healthy and normal behavior.
Hippocampal Slices
Hippocampal slices were prepared from postnatal day 5-7 CD IGS rats (both males and females, from Charles River) as described (Stoppini et al., 1991) and cultured for 1-2 weeks prior to gene transfection. Briefly, we deeply anaesthetized the animal with isoflurane, after which the animal was quickly decapitated and the brain removed. The hippocampi were isolated and cut into 350 mm sections using a tissue chopper (McIlwain). Hippocampal slices were plated on tissue culture inserts (Millicell) fed by tissue medium (for 2.5 L: 20.95 g MEM, 1.19 g HEPES, 1.1 g NaHCO 3 , 5.8 g D-Glucose, 120 mL 25% ascorbic acid, 12.5 mL 200 mM L-Glutamine, 2.5 mL 1 mg/ml Insulin, 500 mL Horse Serum, 5 mL 1 M MgSO 4 , 2.5 mL 1 M CaCl 2 ). Slices were incubated at 35 C in 3% CO2.
Primary Neuronal Culture
Hippocampi dissected from 4 newborn CD IGS rats (postnatal day 0; both males and females; Charles River) were triturated and plated into 35 mm dishes coated with 50 mg/ml PLL (Sigma) in culture medium composed of basal medium Eagle (BME) supplemented with 10% heat-inactivated fetal bovine serum (Invitrogen), 35 mM glucose (Sigma), 1 mM Glutamax (Sigma), 100 U/ml penicillin (Sigma), and 0.1 mg/ml streptomycin (Sigma). Proliferation of non-neuronal cells was inhibited by Cytosine arabinoside (2.5 mM) treatment on the second day after plating.
Cell Lines
Both HeLa cells and HEK293 cells (ATCC) were cultured in Dulbecco's modified eagle medium supplemented with 10% fetal bovine serum at 37 C in 5% CO 2 . Cells were used as an expression platform only, and were thus not rigorously tested for potential contamination from other cell lines.
METHOD DETAILS Plasmids
PaAIP2 was constructed by fusing the codon optimized LOV2 sequence to the amino terminus of autocamtide-2 related inhibitory peptide 2 (AIP2) sequence KKKLRRQEAFDAL (Ishida et al., 1998) with no amino acid linker. The mEGFP-P2A-mCherry-P2A-paAIP2 plasmid was constructed by inserting paAIP2 and mCherry (Shaner et al., 2004) ATNFSLLKQAGDVEENPGP into the pmEGFP-C1 vector which was constructed by introducing the A206K monomeric mutation in pEGFP-C1 (Clontech) (Zacharias et al., 2002) . For construction of mEGFP-CaMKIIa plasmid, the full-length CaMKIIa sequence was inserted into pmEGFP-C1 with a linker amino acid SRLRSRA. For construction of the mCherry-paAIP2 plasmid, the paAIP2 sequence was inserted into pmCherry-C1 with a linker amino acid ASM. The mEGFP-paAIP2-mCherry was constructed by inserting paAIP2 and mCherry into the pmEGFP-C1 vector. The paAIP2 R5A/R6A and paAIP2 I539E (Harper et al., 2004) were prepared by introducing the mutations into AIP2 sequence using Site-Directed Mutagenesis kit (Stratagene). AAV-mEGFP-P2A-paAIP2 was prepared by inserting Camk2a promoter and mEGFP-P2A-paAIP2 into rAAV-9 vector. Virus was produced by University of North Carolina Vector Core. (Johannessen et al., 2010) , and ROCK 287-390 (purchased from Kazusa) genes were inserted into the modified pEGFP-C1 vector with His-tagged mEGFP, respectively. For construction of full-length CaMKIIa, His-tag sequence was fused to the C-terminal of CaMKIIa gene, subsequently, CaMKIIa-His was inserted into the modified pEGFP-C1 vector by replacing EGFP. HEK293 cells were transfected with the plasmids using Lipofectamine2000 (Invitrogen). One day after transfection, cells were lysed and purified by NTA column, similarly to the protein purification from bacteria. The purified protein concentrations were measured by the absorbance of mEGFP (A 488 = 58,000 cm -1 M -1 ) (Murakoshi et al., 2015) .
Protein Purification from Bacteria
Kinase Assay
Standard kinase assays were performed for the indicated time at room temperature with 20-40 nM purified full length CaMKIIa or CaMKIIa 1-325 , 2 mM mCherry-Syn1, 2 mM Calmodulin, 200 mM CaCl 2 , 200 mM ATP, 3 mM sfGFP-paAIP2 in a reaction buffer (50 mM Tris-HCl, pH 7.3, 10 mM MgCl 2 , 2 mM DTT). For PKA, PKC, PAK3, and ROCK2, the experiments were done in the absence of calmodulin and CaCl 2 . For the preparation of autonomous CaMKII, 15 nM full length CaMKIIa was activated for 1 min in the reaction buffer containing 2 mM Calmodulin, 200 mM CaCl 2 , 200 mM ATP. Subsequently, the reaction was stopped by adding 1 mM EDTA. At indicated lanes, samples were continuously illuminated with a light-emitting diode (LED) (M455L2-C1; Thorlabs) at 3 mW/cm 2 (450 nm) during incubation. The reactions were stopped by adding SDS sample buffer, and then analyzed by western blotting. The following antibodies were used: anti-CaMKII (ab52476; Abcam); anti-phosphoT286 CaMKII (p1005-286; PhosphoSolutions); anti-phospho-PKA substrate (RRXS*/T*) (#9624; Cell Signaling Technology) for phosphorylated mCherry-Syn1 detection; HRPanti-mouse and HRP-anti-rabbit (Zymax).
Cell Preparations CA1 pyramidal neurons within hippocampal slices were transfected with biolistic gene transfer (McAllister, 2000) using gold beads (8-12 mg) coated with plasmids containing 30 mg of total cDNA, and imaged 1-3 days after transfection.
HeLa cells were transfected with the plasmids using Lipofectamine2000 (Invitrogen), and imaged 1 day after transfection. For CaMKII activation, 20 mM of A23187 ionophore (Calbiochem) was used. For paAIP2 activation, laser illumination at a wavelength of 473 nm (100 mW/cm 2 ) through the bottom dish was used.
Two-Photon Fluorescence Microscopy
Two-photon imaging was performed using a custom-built two-photon microscope. Monomeric EGFP was excited with a Ti:Sapphire laser (Spectraphysics, Maitai) tuned at a wavelength of 920 nm. The fluorescence was collected by an objective lens (60x, 0.9 NA, Olympus) and detected with photoelectron multiplier tubes (Hamamatsu, H7422-40p) placed after wavelength filters (Chroma, HQ520/60 m-2p for green). The signal was acquired using a data acquisition board (National instruments, PCI-6110) and Scanimage software (Pologruto et al., 2003) .
Two-Photon Glutamate Uncaging and Blue Light Illumination
A second Ti:Sapphire laser tuned at a wavelength of 720 nm was used to uncage 4-Methoxy-7-nitroindolinyl-caged-L-glutamate (MNI-caged glutamate, Tocris) in extracellular solution with a train of 4-6 ms, 5 mW pulses (30 times at 0. 
Double-Trial Training Inhibitory Avoidance Learning
For three days (30-60 min/day) before experiment, mice were habituated to the tethering procedure using a dummy optical patch cable. Behavior experiments were performed following the tethering procedure.
The inhibitory avoidance task was performed following a previous publication with modifications (Irvine et al., 2005) . The training was performed in the following steps. A mouse was placed inside the light chamber (500 lux) within the inhibitory avoidance apparatus, which was custom-made to allow free movement of an animal tethered to a patch cable. The mouse was allowed to explore and adapt to the light chamber for 1 min, after which the door opened. Once it crossed to the dark chamber, the door was closed. ''Crossing'' was defined as the simultaneous detection of three body points (nose-point, center point and tail-base) of the mouse beyond a small entry area bordering light chamber within dark chamber. Cross latency was defined as the time from door opening to crossing. After a delay of 6 s, a mild foot shock (0.5 mA for 2 s) was administered to the mouse. 10 s after the foot shock, the first training trial was finished. After a brief delay ($2 min) for cleaning the apparatus, the training trial was repeated. If the mouse crossed to the dark chamber again within 120 s (cut-off point), the door was closed and the mouse received another foot shock. If the mouse stayed in the light chamber for 120 s, the training was finished. Mice were returned to the home cage once the training was completed. After the 1h laser delivery, short-term memory was assessed by measuring the cross latency to the dark chamber (600 s cut-off point). Twenty-four hours from the double-trial training, long-term memory was assessed (600 s cut-off point). The results of the long-term memory tests were not conclusive and thus not presented. Mice were excluded from the analysis if they did not cross for 120 s in the first training trial. Behavioral data was recorded via an infrared camera interfaced with Ethovision software (Noldus Information Technologies). After the experiments, infected areas in BLA and LA were analyzed from mEGFP fluorescence in histology images. Initial analysis included animals expressing the mEGFP in one hemisphere only (Table S1 ). These animals were excluded from the final analysis (Figure 7 ). The main conclusion was not changed after the removal. Statistical tests were performed with one-way Kruskal-Wallis test followed by Dunn's multiple comparisons test.
Histology, Immunohistochemistry, and Microscopy
Mice were perfused with phosphate-buffered saline (PBS), followed by 4% paraformaldehyde in PBS. 70 mm brain sections were stained for DAPI and mounted. Brain images were obtained on a Zeiss LSM 780 confocal microscope using a 10x objective (z stack, tiled). Acquired images were used to assess the expression of transgene in amygdala and placement of the optical fiber track.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis was performed using the Graphpad Prism 7 software. Statistical parameters including the types of the statistical tests used, exact value of n, precision measures (mean ± SEM) and statistical significance are reported in the figures and figure legends. The significance threshold was placed at a = 0.05 (n.s., p > 0.05; *, p < 0.05; **, p < 0.01; ***, p < 0.001). n denotes the number of cells for HeLa cell experiments, number of slices for LTP experiments and the numbers of spines / neurons for spine imaging experiments.
